Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus
Open Access
- 18 April 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (4), e0153579
- https://doi.org/10.1371/journal.pone.0153579
Abstract
Significant genetic variability in the head region of the influenza A hemagglutinin, the main target of current vaccines, makes it challenging to develop a long-lived seasonal influenza prophylaxis. Vaccines based on the conserved hemagglutinin stalk domain might provide broader cross-reactive immunity. However, this region of the hemagglutinin is immunosubdominant to the head region. Peptide-based vaccines have gained much interest as they allow the immune system to focus on relevant but less immunogenic epitopes. We developed a novel influenza A hemagglutinin-based display platform for H1 hemagglutinin stalk peptides that we identified in an epitope mapping assay using human immune sera and synthetic HA peptides. Flow cytometry and competition assays suggest that the identified stalk sequences do not recapitulate the epitopes of already described broadly neutralizing stalk antibodies. Vaccine constructs displaying 25-mer stalk sequences provided up to 75% protection from lethal heterologous virus challenge in BALB/c mice and induced antibody responses against the H1 hemagglutinin. The developed platform based on a vaccine antigen has the potential to be either used as stand-alone or as prime-vaccine in combination with conventional seasonal or pandemic vaccines for the amplification of stalk-based cross-reactive immunity in humans or as platform to evaluate the relevance of viral peptides/epitopes for protection against influenza virus infection.Funding Information
- Austrian Science Fund (W1224)
- Austrian Science Fund (W1224)
- Austrian Science Fund (P 25092-B13)
- Austrian Science Fund (J 3232)
- Austrian Centre of Industrial Biotechnology
This publication has 49 references indexed in Scilit:
- An analysis of B-cell epitope discontinuityMolecular Immunology, 2012
- A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum EfficacyIn VivoJournal of Virology, 2012
- Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal AntibodiesJournal of Virology, 2011
- H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza VaccinationPLOS ONE, 2011
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A VirusesScience, 2011
- Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A AntibodiesClinical Infectious Diseases, 2011
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences of the United States of America, 2010
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineJCI Insight, 2010
- Monoclonal Antibodies against the Fusion Peptide of Hemagglutinin Protect Mice from Lethal Influenza A Virus H5N1 InfectionJournal of Virology, 2009
- The epitope space of the human proteomeProtein Science, 2008